Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study

Intensive Care Medicine

Volumn 30, Issue 2, 2004, Pages 260-265

  Monchi, Mehran ^a   Berghmans, Denis ^a   Ledoux, Didier ^a   Canivet, Jean Luc ^a   Dubois, Bernard ^a   Damas, Pierre ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Citrate; Hemofiltration; Heparin; Renal replacement therapy

Indexed keywords

CITRATE TRISODIUM; HEPARIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MALE; METABOLIC ALKALOSIS; PH MEASUREMENT; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL;

ADULT; ANTICOAGULANTS; CITRIC ACID; CREATININE; FEMALE; HEMOFILTRATION; HEPARIN; HUMANS; INTENSIVE CARE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UREA;

EID: 1342268344     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-2047-x     Document Type: Article

References (15)

1. Ward DM, Mehta RL (1993) Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 4:S237-S244
2. Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD (1999) A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 27:2224-2228
3. Fiaccadori E, Maggiore U, Rotelli C, Minari M, Melfa L, Cappe G, Cabassi A (2002) Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Intensive Care Med 28:586-593
4. Ohtake Y, Hirasawa H, Sugai T, Oda S, Shiga H, Matsuda K, Kitamura N (1991) Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib Nephrol 93:215-217
5. Tan HK, Baldwin I, Bellomo R (2000) Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 26:1652-1657
6. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 29:575-578
7. Cutts MW, Thomas AN, Kishen R (2000) Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life. Intensive Care Med 26:1694-1697
8. Palsson R, Niles JL (1999) Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997
9. Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT (2000) Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 35:802-811
10. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26-30
11. Mehta RL, McDonald BR, Aguilar MM, Ward DM (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981
12. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C (2002) Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 28:1419-1425
13. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG (2001) Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60:370-374
14. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963
15. Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D (1996) The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276:802-810